It was another mixed start to the day, which was worse than I would have thought given the ICPT data. Even the stocks that were moving seemed to have relatively muted moves and were giving back a substantial portion of the initial bounce. While small caps were not really outperforming large caps, it was another […]
Catalyst Watch – Vol. 2, Edition 23 (7/29/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List: AEZS: I continue […]
July 29 Biotech Update
I had a great email last night that asked me to compare FMI and ILMN and so today I will go a step further and have a day of rumbles with FMI vs ILMN, CNAT vs GALT, and MRK vs PFE. I would talk a little about the broader market and sector but at this […]
Catalyst Watch – Vol. 2, Edition 22 (7/7/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List: Updates AEZS: I’m […]
Catalyst Watch – Vol. 2, Edition 20 (6/20/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List: Updates No updates […]
June 20 Biotech Update
I am glad that I did not miss too much yesterday but it is usually the case that a day or week off does not dramatically change your perspective. It was another good morning for biotechs and I still believe that we are going to make a run at the all-time sector highs if the […]
Catalyst Watch – Vol. 2, Edition 19 (6/13/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List: Updates CNAT: Holding […]
June 5 Biotech Update
The market looks like it is teetering on the edge and perhaps it is the ISIS march across northern Iraq that will be the impetus to send it into the correction. What is interesting is that the biotech sector has held up well in this market weakness (although the weakness has been relatively minor at […]
June 11 Biotech Update
Another relatively slow summer day in the market in terms of trading but the sector seemed to outperform the broader market. Even with that marginal outperformance, I would not read anything new into in that I still believe that the macro is going to drive the next move. That being said I would not be […]
May 20 Biotech Update
The market remains neutral in that stocks are reacting to news in predictable ways and there does not seem any real bid or selling to the sector in general. It seems like people have their positions established and are adjusting them when new information arises but other than that there does not seem to be […]
Catalyst Watch – Vol. 2, Edition 15 (5/15/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List – Update: Updates […]
May 14 Biotech Update- The Wait is Almost Over
Happy ASCO abstracts day. I would expect volatility as we get later into the day and perhaps some significant moves into tomorrow and then ASCO. I know the expectation of no ASCO run up but I still lean against that consensus and expect a run up into ASCO (especially if there is something to spark […]
May 13 Biotech Update- As We Wait for ASCO
Another good start for the sector today and this is certainly feeling like a change in sentiment but we need to remain cautious. That being said, I would lean toward being a more aggressive buyer on pullbacks as we are finally starting to see some bids in the mid to small cap space. I have […]
Catalyst Watch – Vol. 2, Edition 14 (5/8/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List – Update: AEZS: […]
May 8- The Biotech Draft
While there are some stock specific pieces of news, I want to do something a little different today in honor of the NFL draft. I am going to draft my top 10 stocks. This is assuming that I have no positions at all, so this is not what I would be buying now but if […]
Catalyst Watch – Vol. 2, Edition 13 (5/2/14)
Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date published (or are noted), are subject to potential future, pre-catalyst revision and are not intended as investment recommendations. Please read our Disclaimer: (1) Catalyst Watch List – Update: Changes […]
April 9 Biotech Update
As we have been apt to do, this morning was relatively strong but we need to see how this holds up throughout the day. If we are to be optimistic, then having a rally so close to the negative pricing headlines is good as was the decent performance of a number of small caps yesterday. […]
March 31 Biotech Update- Is this the Bounce We are Looking For?
So this seems to be the rally we were looking for but that is assuming it does not fade in the afternoon like every other recent rally attempt. So far the rally is a little more broad based and stronger but we have seen this story before. That being said even if this is the […]
March 28 Biotech Update- Treading Water Can Be Dangerous
So today was another mixed day for biotechs but the large caps still are above the recent lows and even the “bad” news of the sovaldi new scripts being down for a week was not enough to push GILD to new lows or even really have much pin action across the sector. So all of […]
March 19 Biotech Update- Staying Focused
The trading today seemed a little calm (could be because I was out most of the morning) but this is not bad given the recent swings. A period of steady base building might be the most productive outcome but we still need to see many more days before we can be confident as to what […]
